OneChain Immunotherapeutics (private company)

See something wrong or missing? Let us know
Offices:
Barcelona
Business model:
B2B
Investors:
we tracked 3 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

OneChain Immunotherapeutics (OCI), was founded by the Josep Carreras Leukaemia Research Institute, ICREA, and Dr. Pablo Menéndez in Barcelona in June 2020.

Companies with similar profile to OneChain Immunotherapeutics:

CompanyCriteria
Spain ARTHEx Biotech S.L.
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Invivo Capital
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Pulmobiotics S.L
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Invivo Capital
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Gyala Therapeutics
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Invivo Capital
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Telum Therapeutics
54%
  • Similar business models: B2B
  • At least one vc investor: Invivo Capital
  • At least one other investor: CDTI
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Be My Eyes
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Vint
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Flow Neuroscience
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark tiimo
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Norway Prediktor
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Finland Sooma Medical
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Qrem
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Maurten
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Vytrus Biotech
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Biograil
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Elma
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Devicare
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain NEOS Surgery
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain ViveBiotech
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Particle 3D
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Made of Genes
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes